Skip to Content

CLL: Heme: CLL; Registry

informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia

Objective

Overview

The purpose of the InformCLL Registry is to characterize and describe treatment patterns for those initiating treatment with approved oral kinase inhibitors, BCL-2 inhibitors, and other approved anti-CLL /SLL therapies/regimens. This study also evaluates association of treatment patterns with patient characteristics, healthcare resource utilization and patient-reported Health-related Quality of Life (HRQoL).

Key Inclusion Criteria

For a patient to be eligible for participation in this study, all of the following criteria must apply.
  • Age of at least 18 years
  • Clinical diagnosis of CLL/SLL that meets published diagnostic criteria (Hallek 2008)
  • Initiating treatment within ±45 days of enrollment with novel therapies including oral kinase inhibitors (e.g., inhibitors of BTK [e.g., ibrutinib], inhibitors of BCL-2 pathway [ e.g venetoclax] or PI3K [e.g., idelalisib]), or with other anti-CLL therapies/regimens approved at the time of patient enrollment
  • Availability of documentation of previous CLL/SLL treatment and duration of response in the patient's medical records
  • Willing and able to provide informed consent
  • Willing and able to complete PRO instrument
  • Willing and able to provide information on patient survey questionnaire
  • Willing and able to provide a blood sample at time of enrollment

Key Exclusion Criteria

  • Diagnosis of B-cell malignancies other than CLL/SLL
  • Estimated life expectancy <6 months
  • Currently receiving treatment in an interventional clinical trial with a non-approved, investigational agent for CLL/SLL at study entry (note: patients who enroll in an interventional clinical trial after enrollment may remain in the registry)

Phase: N/A

Learn More

ClinicalTrials.Gov

IRB Protocol Number
CLL
Principal Investigator(s)
Asim Pati, M.D

Clinical Trial Categories

  • Hematologic Cancer
Sponsor(s)
Pharmacyclics
How to Participate

Wanda Burdette
864-560-6810
wburdette@gibbscc.org

Was this page helpful?

Yes
No

Thank you for your feedback!

Thank you for your feedback and helping us to improve our website.
There will be no additional response.

Upcoming Events

  • Nov
    16
    Friday
    8:00 AM - 4:30 PM
    Loneliness can be misunderstood & contribute to physical & mental health. We will engage in multiple perspectives, review research & discuss studies that examine loneliness.
  • Nov
    17
    Saturday
    8:30 AM - 4:00 PM
    Register today for your free skin cancer screening, call 864-220-9966.

News & Highlights

Stay Connected!

Get the latest news on the health topics that matter most to you.

Sign up